EFALIZUMAB
UNII XX2MN88N5D

Substance Identification & Data

This profile provides standardized clinical and technical data for Efalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XX2MN88N5D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 214745-43-4 and the RxNorm Concept ID (RxCUI) 356988. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XX2MN88N5D

CAS Registry Number

214745-43-4

RxNorm Concept ID

356988

Detailed Substance Profile

Preferred Name

EFALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C68831

National Cancer Institute reference terminology for clinical and research data.

INN ID

8122

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LL-74

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Efalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EFALIZUMAB

Common Names & Synonyms

EFALIZUMAB [EMA EPAR]

EFALIZUMAB [HSDB]

EFALIZUMAB [INN]

EFALIZUMAB [MART.]

EFALIZUMAB [MI]

EFALIZUMAB [USAN]

EFALIZUMAB [VANDF]

EFALIZUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11A (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HU1124 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HU1124 LIGHT CHAIN, DIMER

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11A (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HU1124 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HU1124 LIGHT CHAIN, DIMER

SYS